Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fluorometholone (fml) (1 trial)
loteprednol (lotemax) (1 trial)
Myopia (Phase 4)
Trials (1 total)
Trial APIs (2 total)